
|Articles|February 7, 2014
Rare Disease Clinical Trial Feasibility Tool
Rare Disease Management announced its rare disease clinical trial feasibility tool
Advertisement
Rare Disease Management (RDM)
, a clinical development company, based in Wilmington, NC focusing primarily on orphan and rare diseases, announced its rare disease clinical trial feasibility tool that enables pharmaceutical, biotech and CRO clients to best identify the top investigators in orphan and rare diseases. The tool— ExpertSense—was developed by RDM in collaboration with the Technical University of Denmark Bioinformatics team. That team was also responsible for the introduction of FindZebra, a investigator tool that helps give rare disease investigators a hypothesis for rare diseases.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5



